LORBRIQUA 25MG TABLET

Form: Tablets

Pack Size: 15 TABLETS

Marketed by: PFIZER PRODUCTS INDIA PVT LTD (ONCOLOGY DIV)

MRP: ₹47812.50

PFIZER PRODUCTS INDIA PVT LTD (ONCOLOGY DIV): Lorbriqua 25MG Tablet, 15 tablets, salt lorlatinib 25mg. Its MRP stays at Rs 47,812.50 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 36,428.57. Group: third-generation ALK inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: cholesterol rise is expected; lipid-lowering medicine is often added. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.